Interaksi Amfetamin dan dekstroamfetamin dan Rasagilin

Amfetamin dan dekstroamfetamin dan Rasagilin: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Amfetamin dan dekstroamfetamin (Adderall XR) · berlaku sejak 2026-04-30

Mayor

Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see Adverse Reactions ( 6.2 )] . taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive…

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

During or within 14 days following the administration of monoamine oxidase inhibitors (MAOI).

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

Serotonin Syndrome: Increased risk when coadministered with serotonergic agents (e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans), but also during overdosage situations.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

Serotonin Syndrome Serotonin syndrome, a potentially life-threatening reaction, may occur when amphetamines are used in combination with other drugs that affect the serotonergic neurotransmitter systems such as MAOIs, selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, tricyclic antidepressants, fentanyl,…

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

Concomitant use of ADDERALL XR with MAOI drugs is contraindicated [see Contraindications ( 4 )] .

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed

Dari label Rasagilin (Rasagiline) · berlaku sejak 2020-06-30

Moderat

Hypertensive crisis has been reported in patients taking the recommended dose of rasagiline and sympathomimetic medications.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Severe hypertension has been reported in patients taking the recommended dose of rasagiline and ophthalmic drops containing sympathomimetic medications.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Nevertheless, caution should be exercised when concomitantly using recommended doses of rasagiline with any sympathomimetic medications including nasal, oral, and ophthalmic decongestants and cold remedies.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Minor

Sympathomimetic Medications The concomitant use of rasagiline and sympathomimetic medications was not allowed in clinical studies.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Minor

Severe hypertensive reactions have followed the administration of sympathomimetics and nonselective MAO inhibitors.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.